Curing disease has the greatest potential to reduce suffering and grief. It's also the best way to improve the bottom line of spending on health. Real economic growth depends on our ability to develop medical solutions that eliminate untimely death and disability.No one can do this work alone. Expediting cures requires collaboration.
In a week, hundreds of medical research leaders and decision-makers from different sectors will come together at the inaugural Partnering for Cures meeting to do just that. Join us.
This first-of-its-kind meeting will be held December 1-3 in New York City.
Program: More than 80 confirmed speakers including:
- Pfizer's Jeffrey Kindler
- FDA's Joshua Sharfstein
- Dana-Farber Cancer Institute’s Edward Benz
- Dr. Susan Love Research Foundation’s Susan Love
- Biotechnology Industry Organization’s James Greenwood
- Harvard Medical School's Levi Garraway
- Johnson & Johnson’s Garry Neil
- Blueprint Research & Design’s Lucy Bernholz
- NIH Chemical Genomics Center’s Christopher Austin
- Eli Lilly & Company's Gail Cassell
- Juvenile Diabetes Research Foundation's Alan Lewis
- International AIDS Vaccine Initiative's Seth Berkley
Partnering: customized partnering system facilitates one-on-one connections among potential collaborators; therapeutic affinity roundtables jumpstarts networking across sectors; networking opportunities that will link you to key organizations whose mission and strategies match your priorities
Participants: More than 400 attendees from more 350 organizations are registered. They represent a broad range of sectors: philanthropy, foundations, industry, academia, government, media and venture capital.
Don’t miss this opportunity to help accelerate the time it takes to develop new medical treatments. Register now.
1 comment:
The Myelin Repair Foundation is looking forward to participating in Partnering for Cures this week. We'll be blogging about the conference at our blog.
Thanks for organizing this event!
Post a Comment